146 related articles for article (PubMed ID: 38655589)
1. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
[TBL] [Abstract][Full Text] [Related]
2. Molecular Machinery of the Triad Holin, Endolysin, and Spanin: Key Players Orchestrating Bacteriophage-Induced Cell Lysis and their Therapeutic Applications.
Samir S
Protein Pept Lett; 2024; 31(2):85-96. PubMed ID: 38258777
[TBL] [Abstract][Full Text] [Related]
3. Virulence-associated factors as targets for phage infection.
de Melo AG; Morency C; Moineau S
Curr Opin Microbiol; 2024 Jun; 79():102471. PubMed ID: 38569419
[TBL] [Abstract][Full Text] [Related]
4. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa.
Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M
Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246
[TBL] [Abstract][Full Text] [Related]
5. Implications of lytic phage infections inducing persistence.
Sanchez-Torres V; Kirigo J; Wood TK
Curr Opin Microbiol; 2024 Jun; 79():102482. PubMed ID: 38714140
[TBL] [Abstract][Full Text] [Related]
6. Current Knowledge and Perspectives of Phage Therapy for Combating Refractory Wound Infections.
Wang B; Du L; Dong B; Kou E; Wang L; Zhu Y
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791502
[TBL] [Abstract][Full Text] [Related]
7. Phage therapy: breathing new tactics into lower respiratory tract infection treatments.
Vaezi A; Healy T; Ebrahimi G; Rezvankhah S; Hashemi Shahraki A; Mirsaeidi M
Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38925791
[TBL] [Abstract][Full Text] [Related]
8. Making the leap from technique to treatment - genetic engineering is paving the way for more efficient phage therapy.
Lewis JM; Williams J; Sagona AP
Biochem Soc Trans; 2024 Jun; 52(3):1373-1384. PubMed ID: 38716972
[TBL] [Abstract][Full Text] [Related]
9. Optimizing bacteriophage treatment of resistant
Ulrich L; Steiner LX; Giez C; Lachnit T
mSphere; 2024 Jun; ():e0070723. PubMed ID: 38934592
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.
Green SI; Clark JR; Santos HH; Weesner KE; Salazar KC; Aslam S; Campbell JW; Doernberg SB; Blodget E; Morris MI; Suh GA; Obeid K; Silveira FP; Filippov AA; Whiteson KL; Trautner BW; Terwilliger AL; Maresso A
Clin Infect Dis; 2023 Oct; 77(8):1079-1091. PubMed ID: 37279523
[TBL] [Abstract][Full Text] [Related]
11. A novel endolysin from an Enterococcus faecalis phage and application.
Xiang Y; Wang S; Huang H; Li X; Wei Y; Li H; Ji X
Microb Pathog; 2024 Jul; 192():106689. PubMed ID: 38750777
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of repeated intravenous phage doses on mammalian host-phage interactions.
Tan X; Chen K; Jiang Z; Liu Z; Wang S; Ying Y; Zhang J; Yuan S; Huang Z; Gao R; Zhao M; Weng A; Yang Y; Luo H; Zhang D; Ma Y
J Virol; 2024 Jan; 98(1):e0135923. PubMed ID: 38084959
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophages and bacterial extracellular vesicles, threat or opportunity?
Meidaninikjeh S; Mohammadi P; Elikaei A
Life Sci; 2024 Aug; 350():122749. PubMed ID: 38821215
[TBL] [Abstract][Full Text] [Related]
14.
Li S; Wei B; Xu L; Cong C; Murtaza B; Wang L; Li X; Li J; Xu M; Yin J; Xu Y
J Virol; 2024 Jun; ():e0046724. PubMed ID: 38864621
[No Abstract] [Full Text] [Related]
15. Phage Therapy for Respiratory Infections: Opportunities and Challenges.
Khosravi A; Chen Q; Echterhof A; Koff JL; Bollyky PL
Lung; 2024 Jun; 202(3):223-232. PubMed ID: 38772946
[TBL] [Abstract][Full Text] [Related]
16. Research Progress on Strategies for Improving the Enzyme Properties of Bacteriophage Endolysins.
Wang Y; Wang X; Liu X; Lin B
J Microbiol Biotechnol; 2024 Jun; 34(6):1189-1196. PubMed ID: 38693045
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a Thermostable Endolysin of the
Golosova NN; Khlusevich YA; Morozova VV; Matveev AL; Kozlova YN; Tikunov AY; Panina EA; Tikunova NV
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257793
[TBL] [Abstract][Full Text] [Related]
18. The Medicinal Phage-Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation.
Faltus T
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543808
[TBL] [Abstract][Full Text] [Related]
19. Genetically Engineered Phages: a Review of Advances over the Last Decade.
Pires DP; Cleto S; Sillankorva S; Azeredo J; Lu TK
Microbiol Mol Biol Rev; 2016 Sep; 80(3):523-43. PubMed ID: 27250768
[TBL] [Abstract][Full Text] [Related]
20. Disruption of Biofilm by Bacteriophages in Clinically Relevant Settings.
Kovacs CJ; Rapp EM; McKenzie SM; Mazur MZ; Mchale RP; Brasko B; Min MY; Burpo FJ; Barnhill JC
Mil Med; 2024 May; 189(5-6):e1294-e1302. PubMed ID: 37847552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
